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Purpose
T h ea i mo ft h ep r e s e n ts t u d yi st oo b s e r v et h ee f f i c a c y
of Ojeoksan and the difference in the results induced by
extracting methods among mixtures of independently
extracted herbs (MIE group), extract from combined
decoction (ECD group) and placebo (Placebo group).
Methods
The study was approved by the Ethics Committee of
Kyunghee Oriental Medical Center in Seoul, Korea. Sixty
subjects (M:F=26:34) with low back pain were recruited
in the study and randomly allocated to MIE group, ECD
group and Placebo group. During 4 weeks, the MIE
group took the Ojeoksan Mixture of Independently
Extracted Herbs, the ECD group took the Ojeoksan
E x t r a c tf r o mc o m b i n e dD e c o c t i o n ,a n dt h eP l a c e b o
group took a placebo. The effect of Ojeoksan on pain
was measured with VAS (Visual Analogue Scale)
and SF-36 Bodily Pain scale. Disability was measured
with RMDQ (Roland-Morris Disability Questionnaire).
General health was measured with the SF-36 (36-Item
Short-Form Quality of Life Questionnaire) and range of
motion was measured with MMST (Modified-Modified
Schober Test) at baseline, 2 weeks and 4 weeks. Efficacy
was evaluated with the SPSS 12.0 paired t-test for
intragroup testing and ANCOVA (Analysis of covar-
iance) for intergroup testing.
Results
After 4 weeks, the MIE group showed significant improve-
ment on VAS, RMDQ and MMST; the ECD group
showed significant improvement on VAS, SF-36 Bodiliy
Pain scale, RMDQ, SF-36 and MMST; the Placebo group
showed significant improvement on VAS and MMST by
paired t-test. In RMDQ, each group showed a significant
difference, but other scales showed no difference analysed
by ANCOVA.
Conclusion
According to the results, Ojeoksan is more efficacious on
pain, disability and general health for low back pain
patients than placebo. Ojeoksan extract from combined
decoction is more efficacious than Ojeoksan mixture of
independently extracted herbs and placebo on disability
caused by lumbar back pain.
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